Bram M. W. Diederen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Bram M. W. Diederen has a total of 47 co-authors. Here are the top co-authors by number of shared publications:
Marcel F. Peeters
Laboratory of Medical Microbiology and Immunology; St. Elisabeth Hospital; 5000 AS Tilburg The Netherlands
7 shared publicationsM. F. Peeters
St. Elisabeth Hospital
5 shared publicationsCaroline M. A. de Jong
Laboratory of Medical Microbiology and Immunology; St. Elisabeth Hospital; 5000 AS Tilburg The Netherlands
3 shared publicationsJ. P. Bruin
The Regional Laboratory of Public Health, Boerhaavelaan 26, 2035 RC, Haarlem, The Netherlands
3 shared publicationsJan A. J. W. Kluytmans
Laboratory for Medical Microbiology and Immunology, St. Elisabeth Hospital, Tilburg, The Netherlands,1 Laboratory for Microbiology and Infection Control, Amphia Hospital, Breda, The Netherlands,2 Department of Medical Microbiology and Infection Control, VU University Medical Center, Amsterdam, The Netherlands3
3 shared publicationsAnneke van der Zee
Laboratory of Medical Microbiology and Immunology; St. Elisabeth Hospital; 5000 AS Tilburg The Netherlands
2 shared publications
Latest Publications
- Open Access
- 8 March 2016
- Published by Springer Nature in Antimicrobial Resistance & Infection Control
- Vol. 5 (1) , 1-10
Prevalence, risk factors and molecular epidemiology of highly resistant gram negative rods in hospitalized patients in the Dutch region Kennemerland
This paper describes (1) the Highly Resistant Gram Negative Rod (HR-GNR) prevalence rate, (2) their genotypes, acquired resistance genes and (3) associated risk factors of HR-GNR colonization among the hospitalized population in the Dutch region Kennemerland. Between 1 October 2013 and 31 March 2014, cross-sectional prevalence measurements were performed in three regional hospitals as part of each hospitals infection control program. Rectal swabs were analyzed at the Regional Public Health Laboratory Kennemerland by direct culturing. Genotypes and acquired resistance genes of positive isolates were determined using Whole Genome Sequencing with the MiSeq instrument (Illumina). Association between several independent variables and HR-GNR positivity was examined using logistic regression models. Out of 427 patients, 24 HR-GNR positive isolates were recovered from 22 patients, resulting in a regional HR-GNR colonization prevalence (95 % CI) of 5.2 % (3.6–7.9). Of these 22 positive patients, 15 were Extended Spectrum Beta-Lactamase (ESBL) positive (3.5 % (2.1–5.7)), 7 patients were positive for a Fluoroquinolones and Aminoglycosides (Q&A) resistant Enterobacteriaceae (1.6 % (0.8–3.3)) and from one patient (0.2 % (0–1.3)) a Stenotrophomonas maltophilia resistant towards co-trimoxazole was isolated. No carbapenemase producing Enterobacteriaceae (CPE), multi-resistant Acinetobacter species or multi-resistant Pseudomonas aeruginosa were isolated. The ESBL genes found were bla CTX-M-1 (n = 4, 25.0 %), bla CTX-M-15 (n = 3, 18.8 %), bla CTX-M-27 (n = 2, 12.5 %), bla CTX-M-14b (n = 2, 12.5 %), bla CTX-M-9 (n = 2, 12.5 %), bla CTX-M-14 (n = 1, 6.3 %), bla CTX-M-3 (n = 1, 6.3 %), bla SHV-11 (n = 1, 6.3 %) and bla SHV-12 (n = 1, 6.3 %). Being known HR-GNR positive in the past was the only significant associated risk factor for HR-GNR positivity, odds ratio (95 % CI): 7.32 (1.82–29.35), p-value = 0.005. Similar ESBL prevalence rates and genotypes (3.5 %) were found in comparison to other Dutch studies. When previously HR-GNR positive patients are readmitted, they should be screened for HR-GNR colonization since colonization with GR-GNRs could be prolonged. We recommend for future studies to include all defined HR-GNRs in addition to ESBLs in prevalence studies, in order to obtain a more comprehensive overview of colonization with HR-GNRs.
- 8 March 2016
- Published by Springer Nature in Antimicrobial Resistance & Infection Control
- Vol. 5 (1) , 1-10
Open AccessPrevalence, risk factors and molecular epidemiology of highly resistant gram negative rods in hospitalized patients in the Dutch region Kennemerland
This paper describes (1) the Highly Resistant Gram Negative Rod (HR-GNR) prevalence rate, (2) their genotypes, acquired resistance genes and (3) associated risk factors of HR-GNR colonization among the hospitalized population in the Dutch region Kennemerland. Between 1 October 2013 and 31 March 2014, cross-sectional prevalence measurements were performed in three regional hospitals as part of each hospitals infection control program. Rectal swabs were analyzed at the Regional Public Health Laboratory Kennemerland by direct culturing. Genotypes and acquired resistance genes of positive isolates were determined using Whole Genome Sequencing with the MiSeq instrument (Illumina). Association between several independent variables and HR-GNR positivity was examined using logistic regression models. Out of 427 patients, 24 HR-GNR positive isolates were recovered from 22 patients, resulting in a regional HR-GNR colonization prevalence (95 % CI) of 5.2 % (3.6–7.9). Of these 22 positive patients, 15 were Extended Spectrum Beta-Lactamase (ESBL) positive (3.5 % (2.1–5.7)), 7 patients were positive for a Fluoroquinolones and Aminoglycosides (Q&A) resistant Enterobacteriaceae (1.6 % (0.8–3.3)) and from one patient (0.2 % (0–1.3)) a Stenotrophomonas maltophilia resistant towards co-trimoxazole was isolated. No carbapenemase producing Enterobacteriaceae (CPE), multi-resistant Acinetobacter species or multi-resistant Pseudomonas aeruginosa were isolated. The ESBL genes found were bla CTX-M-1 (n = 4, 25.0 %), bla CTX-M-15 (n = 3, 18.8 %), bla CTX-M-27 (n = 2, 12.5 %), bla CTX-M-14b (n = 2, 12.5 %), bla CTX-M-9 (n = 2, 12.5 %), bla CTX-M-14 (n = 1, 6.3 %), bla CTX-M-3 (n = 1, 6.3 %), bla SHV-11 (n = 1, 6.3 %) and bla SHV-12 (n = 1, 6.3 %). Being known HR-GNR positive in the past was the only significant associated risk factor for HR-GNR positivity, odds ratio (95 % CI): 7.32 (1.82–29.35), p-value = 0.005. Similar ESBL prevalence rates and genotypes (3.5 %) were found in comparison to other Dutch studies. When previously HR-GNR positive patients are readmitted, they should be screened for HR-GNR colonization since colonization with GR-GNRs could be prolonged. We recommend for future studies to include all defined HR-GNRs in addition to ESBLs in prevalence studies, in order to obtain a more comprehensive overview of colonization with HR-GNRs.
- 9 April 2014
- Published by American Society for Microbiology
- p. 47-50
Detection of Legionella pneumophila DNA in Serum Samples from Patients with Legionnaires' Disease
- 9 April 2014
- Published by American Society for Microbiology
- p. 47-50
Detection of Legionella pneumophila DNA in Serum Samples from Patients with Legionnaires' Disease
- 26 September 2012
- Published by Springer Nature in European Journal of Clinical Microbiology & Infectious Diseases
- Vol. 32 (3) , 333-334
Evaluation of Meridian TRU Legionella®, a new rapid test for detection of Legionella pneumophila serogroup 1 antigen in urine samples
We evaluated the ability of a new antigen test (TRU Legionella® assay, Meridian Bioscience, Cincinnati, OH, USA) to detect Legionella pneumophila serogroup 1 antigen in urine. The results were compared with those obtained with the Binax NOW® urinary antigen test (Binax, Portland, ME, USA). The sensitivities and specificities were 73 % [95 % confidence interval (CI), 65 to 81 %] and 100 %, respectively, for the Meridian TRU Legionella test and 77 % (95 % CI, 68 to 84 %) and 100 %, respectively, for the Binax NOW urinary antigen test. The sensitivity of the Meridian TRU Legionella test increased to 81 % if tests were re-examined after 60 min of incubation. Prolonged incubation did not affect the specificity. We conclude that both assays evaluated have similar performance characteristics and are suitable for the rapid diagnosis of Legionnaires’ disease.
- 26 September 2012
- Published by Springer Nature in European Journal of Clinical Microbiology & Infectious Diseases
- Vol. 32 (3) , 333-334
Evaluation of Meridian TRU Legionella®, a new rapid test for detection of Legionella pneumophila serogroup 1 antigen in urine samples
We evaluated the ability of a new antigen test (TRU Legionella® assay, Meridian Bioscience, Cincinnati, OH, USA) to detect Legionella pneumophila serogroup 1 antigen in urine. The results were compared with those obtained with the Binax NOW® urinary antigen test (Binax, Portland, ME, USA). The sensitivities and specificities were 73 % [95 % confidence interval (CI), 65 to 81 %] and 100 %, respectively, for the Meridian TRU Legionella test and 77 % (95 % CI, 68 to 84 %) and 100 %, respectively, for the Binax NOW urinary antigen test. The sensitivity of the Meridian TRU Legionella test increased to 81 % if tests were re-examined after 60 min of incubation. Prolonged incubation did not affect the specificity. We conclude that both assays evaluated have similar performance characteristics and are suitable for the rapid diagnosis of Legionnaires’ disease.
- 1 March 2012
- Published by Microbiology Society in Journal of Medical Microbiology
- Vol. 61 (3) , 452
Evaluation of four screening protocols for detection of extended-spectrum β-lactamase-producing members of the Enterobacteriaceae
- 1 March 2012
- Published by Microbiology Society in Journal of Medical Microbiology
- Vol. 61 (3) , 452
Evaluation of four screening protocols for detection of extended-spectrum β-lactamase-producing members of the Enterobacteriaceae
- Open Access
- 1 May 2010
- Published by Centers for Disease Control and Prevention (CDC) in Emerging Infectious Diseases
- Vol. 16 (5) , 897-898
Rapid Antigen Test for Pandemic (H1N1) 2009 Virus
- 1 May 2010
- Published by Centers for Disease Control and Prevention (CDC) in Emerging Infectious Diseases
- Vol. 16 (5) , 897-898
Open AccessRapid Antigen Test for Pandemic (H1N1) 2009 Virus
- 29 April 2010
- Published by Springer Nature in European Journal of Clinical Microbiology & Infectious Diseases
- Vol. 29 (7) , 899-900
Evaluation of Legionella V-TesT for the detection of Legionella pneumophila antigen in urine samples
- 29 April 2010
- Published by Springer Nature in European Journal of Clinical Microbiology & Infectious Diseases
- Vol. 29 (7) , 899-900
Evaluation of Legionella V-TesT for the detection of Legionella pneumophila antigen in urine samples
- 1 September 2009
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 47 (9) , 3066-3067
Enrichment Broth and Detection of Extended-Spectrum-Beta-Lactamase-Producing Bacteria in Throat and Rectal Surveillance Cultures of Intensive Care Unit Patients
- 1 September 2009
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 47 (9) , 3066-3067
Enrichment Broth and Detection of Extended-Spectrum-Beta-Lactamase-Producing Bacteria in Throat and Rectal Surveillance Cultures of Intensive Care Unit Patients
- 1 July 2009
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 47 (7) , 2272-2274
Evaluation of the Oxoid Xpect Legionella Test Kit for Detection of Legionella pneumophila Serogroup 1 Antigen in Urine
We evaluated a new immunochromatographic assay (Oxoid Xpect Legionella test kit) for the ability to detect Legionella pneumophila serogroup 1 antigen in urine. The results were compared with those obtained with the Binax NOW urinary antigen test by following the manufacturers' instructions. The sensitivities and specificities were estimated to be 89 and 100%, respectively, for the Oxoid Xpect Legionella test kit and 86 and 100%, respectively, for the Binax NOW test.
- 1 July 2009
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 47 (7) , 2272-2274
Evaluation of the Oxoid Xpect Legionella Test Kit for Detection of Legionella pneumophila Serogroup 1 Antigen in Urine
We evaluated a new immunochromatographic assay (Oxoid Xpect Legionella test kit) for the ability to detect Legionella pneumophila serogroup 1 antigen in urine. The results were compared with those obtained with the Binax NOW urinary antigen test by following the manufacturers' instructions. The sensitivities and specificities were estimated to be 89 and 100%, respectively, for the Oxoid Xpect Legionella test kit and 86 and 100%, respectively, for the Binax NOW test.
- 1 January 2009
- Published by Taylor & Francis in Scandinavian Journal of Infectious Diseases
- Vol. 41 (1) , 45-50
Detection of respiratory viruses and Legionella spp. by real-time polymerase chain reaction in patients with community acquired pneumonia
We conducted a study on throat swabs obtained from a group of hospitalized patients with community acquired pneumonia (CAP). Throat swab specimens from 242 adults admitted to hospital with CAP were tested. In total, 1 or more aetiological agents were identified by real-time PCR in 55 (23%) patients. The most frequently detected pathogens were coronavirus (17%), parainfluenza virus (6%) and influenza virus (4%). Overall, viral pathogens were identified by conventional techniques in 7 (2%) patients, and real-time PCR in 50 (21%) patients (pp=0.06). A significantly higher percentage of mortality was present in patients with a mixed bacterial and viral infection. L. pneumophila PCR was positive in only 3 out of 11 cases (27%) of Legionnaires’ disease (LD). This study demonstrates that real-time PCR can increase the number of microbiological detections of respiratory pathogens, mainly as a result of detection of respiratory viruses.
- 1 January 2009
- Published by Taylor & Francis in Scandinavian Journal of Infectious Diseases
- Vol. 41 (1) , 45-50
Detection of respiratory viruses and Legionella spp. by real-time polymerase chain reaction in patients with community acquired pneumonia
We conducted a study on throat swabs obtained from a group of hospitalized patients with community acquired pneumonia (CAP). Throat swab specimens from 242 adults admitted to hospital with CAP were tested. In total, 1 or more aetiological agents were identified by real-time PCR in 55 (23%) patients. The most frequently detected pathogens were coronavirus (17%), parainfluenza virus (6%) and influenza virus (4%). Overall, viral pathogens were identified by conventional techniques in 7 (2%) patients, and real-time PCR in 50 (21%) patients (pp=0.06). A significantly higher percentage of mortality was present in patients with a mixed bacterial and viral infection. L. pneumophila PCR was positive in only 3 out of 11 cases (27%) of Legionnaires’ disease (LD). This study demonstrates that real-time PCR can increase the number of microbiological detections of respiratory pathogens, mainly as a result of detection of respiratory viruses.
- 1 February 2008
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 46 (2) , 671-677
Utility of Real-Time PCR for Diagnosis of Legionnaires’ Disease in Routine Clinical Practice
The main aim of our study was to determine the added value of PCR for the diagnosis of Legionnaires’ disease (LD) in routine clinical practice. The specimens were samples submitted for routine diagnosis of pneumonia from December 2002 to November 2005. Patients were evaluated if, in addition to PCR, the results of at least one of the following diagnostic tests were available: (i) culture for Legionella spp. on buffered charcoal yeast extract agar or (ii) detection of Legionella pneumophila antigen in urine specimens. Of the 151 evaluated patients, 37 (25%) fulfilled the European Working Group on Legionella Infections criteria for a confirmed case of LD (the “gold standard”). An estimated sensitivity, specificity, and overall percent agreement of 86% (32 of 37; 95% confidence interval [CI] = 72 to 95%), 95% (107 of 112; 95% CI = 90 to 98%), and 93% (139 of 149), respectively, were found for 16S rRNA-based PCR, and corresponding values of 92% (34 of 37; 95% CI = 78 to 98%), 98% (110 of 112; 95% CI = 93 to 100%), and 97% (144 of 149), respectively, were found for the mip gene-based PCR. A total of 35 patients were diagnosed by using the urinary antigen test, and 34 were diagnosed by the 16S rRNA-based PCR. With the mip gene PCR one more case of LD ( n = 36; not significant) was detected. By combining urinary antigen test and the mip gene PCR, LD was diagnosed in an additional 4 (11%) patients versus the use of the urinary antigen test alone. The addition of a L. pneumophila -specific mip gene PCR to a urinary antigen test is useful in patients with suspected LD who produce sputum and might allow the early detection of a significant number of additional patients.
- 1 February 2008
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 46 (2) , 671-677
Utility of Real-Time PCR for Diagnosis of Legionnaires’ Disease in Routine Clinical Practice
The main aim of our study was to determine the added value of PCR for the diagnosis of Legionnaires’ disease (LD) in routine clinical practice. The specimens were samples submitted for routine diagnosis of pneumonia from December 2002 to November 2005. Patients were evaluated if, in addition to PCR, the results of at least one of the following diagnostic tests were available: (i) culture for Legionella spp. on buffered charcoal yeast extract agar or (ii) detection of Legionella pneumophila antigen in urine specimens. Of the 151 evaluated patients, 37 (25%) fulfilled the European Working Group on Legionella Infections criteria for a confirmed case of LD (the “gold standard”). An estimated sensitivity, specificity, and overall percent agreement of 86% (32 of 37; 95% confidence interval [CI] = 72 to 95%), 95% (107 of 112; 95% CI = 90 to 98%), and 93% (139 of 149), respectively, were found for 16S rRNA-based PCR, and corresponding values of 92% (34 of 37; 95% CI = 78 to 98%), 98% (110 of 112; 95% CI = 93 to 100%), and 97% (144 of 149), respectively, were found for the mip gene-based PCR. A total of 35 patients were diagnosed by using the urinary antigen test, and 34 were diagnosed by the 16S rRNA-based PCR. With the mip gene PCR one more case of LD ( n = 36; not significant) was detected. By combining urinary antigen test and the mip gene PCR, LD was diagnosed in an additional 4 (11%) patients versus the use of the urinary antigen test alone. The addition of a L. pneumophila -specific mip gene PCR to a urinary antigen test is useful in patients with suspected LD who produce sputum and might allow the early detection of a significant number of additional patients.